19 May 2017 (Friday)
Time Programme
09:00 – 09:30 Registration
09:30 – 11:00 Plenary Lecture 1: Basic Sciences
Chairpersons: X.Y. GUAN (Hong Kong), Tak-wah MAK (Canada)

Beyond Oncogenes: Emerging Strategies in Anti-cancer Targets

Tak-wah MAK (Canada)

Whole-exome Sequencing-identified Macrophage-stimulating Receptor 1 (MST1R) in NPC Genetic Susceptibility

Maria LUNG (Hong Kong)

Hepatocellular Carcinoma Treatment at the Intersection between Antiangiogenic Therapy and Immunotherapy

Salon 5-6
11:00 – 11:30 Coffee Tea Break & Exhibition
11:30 – 12:45 Concurrent Session 1: Sarcoma
Chairpersons: Ying-lee LAM (Hong Kong),
Tony Wai-hung SHEK (Hong Kong)

Excision of Soft Tissue Sarcoma: Preopeartive Planning

Ying-lee LAM (Hong Kong)

Advances of Radiation Oncology in the Management of Soft Tissue Sarcoma
Brian O’SULLIVAN (Canada)

An Update and Concise Guide to Sarcomas
Robin JONES (UK)
Salon 5-6
Concurrent Session 2: Drug Development in Oncology
Chairperson: Lilian SIU (Canada)

Early Phase Clinical Trials in the Era of Immunotherapy
Lilian SIU (Canada)

The Challenges and Opportunities of Early Clinical Trials in Hong Kong
Joanne CHIU (Hong Kong)

Early Phase Clinical Trials in the Era of Genomic Medicine
Timothy YAP (USA)

Salon 1-4
12:45 – 14:15 Lunch Symposium (Sponsored by Amgen)
Chairperson: Chi-leung CHIANG (Hong Kong)

Optimizing Treatment Outcomes in Metastatic Colorectal Cancer
Niall TEBBUTT (Australia)

Anti-EGFR Therapy: the Right Patient at the Right Time
Ka-on LAM (Hong Kong)

Salon 5-6
Lunch Symposium (Sponsored by BMS)
Chairpersons: Thomas YAU (Hong Kong), Roger NGAN (Hong Kong)

Emerging Treatment in Recurrent/Metastatic Head and Neck Cancers: A Changing Landscape with Potential to Impact on Primary Treatment of Locally Advanced Disease

Management of Advanced Hepatocellular Carcinoma: At the Dawn of a New Era
Thomas YAU (Hong Kong)
Salon 1-4
14:15 – 15:30 Concurrent Session 3: Hepatocellular Cancer
Chairpersons: Tan-to CHEUNG (Hong Kong),
Masatoshi KUDO (Japan)

Role of SBRT for the Management of HCC
Laura DAWSON (Canada)

The Role of Radioembolization in the Management of HCC
Pierce Kah-hoe CHOW (Singapore)

Latest Advances in Using Molecular Targeted Therapy in Advanced HCC Patients
Masatoshi KUDO (Japan)

Salon 5-6
Concurrent Session 4: Neuroendocrine Tumour
Chairpersons: Foon-yiu CHEUNG (Hong Kong),
Roland LEUNG (Hong Kong)

Update on Pathology of Neuroendocrine Tumors (NET) of the GI Tract
Tony Wai-hung SHEK (Hong Kong)

Progress in the Land of Small Tumours: Recent Advances and Future Directions in Advanced Neuroendocrine Tumours
James YAO (USA)

Use of Peptide Receptor Radionuclide Therapy (PPRT) for
Treatment of Neuroendocrine Tumour

Thomas Kam-chau CHENG (Hong Kong)
Salon 1-4
15:30 – 16:00 Coffee Tea Break & Exhibition
16:00 – 16:30 Opening Ceremony
Salon 5-6
16:30 – 18:30 Plenary Lecture 2: Precision Medicine
Chairpersons: Victor LEE (Hong Kong), Irene NG (Hong Kong)

Personalized Medicine in Novel Clinical Candidates in Metabolic Pathways
Tak-wah MAK (Canada)

Advanced Melanoma in 2017: Immunotherapy vs. Targeted Therapy
Victoria ATKINSON (Australia)

Pan Histology Development of Targeted Therapies and Impact on Oncology Practice
Steven Potts (USA)

Management of Advanced Lung Cancer in the Era of Precision Medicine
Salon 5-6
18:30 - 19:45 Satellite Symposium (Sponsored by Roche)
Chairperson: James HO (Hong Kong), Victor LEE (Hong Kong)

Updates on Cancer Immunotherapy (CIT) in Advanced NSCLC
Kenneth O’BYRNE (Australia)

PD-L1 Inhibition in Advanced NSCLC in Real-world Setting
Ross SOO (Singapore)
Salon 5-6
19:45 - Gala Dinner (Sponsored by Roche)
Salon 1-4


20 May 2017 (Saturday)
Time Programme
08:00 – 08:30 Registration
08:30 – 10:30 Plenary Lecture 3: Renaissance of Immuno-Oncology in Cancer Treatment
(Sponsored by MSD)
Chairpersons: Han-chong TOH (Singapore), Thomas YAU (Hong Kong)

Tumour Heterogeneity and Immune Surveillance
Charles SWANTON (UK)

Immune Checkpoint Inhibitors in NSCLC: Now and Future

Role of Biomarker in NSCLC in the Era of Immuno-Oncology
Rina HUI (Australia)

The Role of Immunotherapy in Gastrointestinal Cancer
Dung Thi LE (USA)
Salon 5-6
10:30 – 10:50 Coffee Tea Break & Exhibition (Sponsored by AstraZeneca)
10:50 – 12:05 Concurrent Session 5: Clinical Oncology
Chairpersons: Amy CHANG (Hong Kong), Dora KWONG (Hong Kong)

Treatment of Nonsmall Cell Lung Cancer Patients with Uncommon Driver Mutations
James Chih-hsin YANG (Taiwan)

Recent Advances of SBRT for Hepatocellular Carcinoma
Jinsil SEONG (South Korea)

Combinatorial Immune Therapies to Enhance Outcomes in Solid Cancers
Salon 5-6
Concurrent Session 6: Haematology
Chairperson: Yok-lam KWONG (Hong Kong)

Novel Treatment Strategies in ALL: The Evolving Role of Immunotherapy
David RITCHIE (Australia) (Sponsored by Amgen)

Checkpoint Inhibition Where Do We Go from Here
Yok-lam KWONG (Hong Kong)

Immunotherapy: Changing the Landscape from Hodgkin to NK/T-cell Lymphoma
Daryl TAN (Singapore) (Sponsored by MSD)

Salon 1-4
12:05 – 13:30 Lunch Symposium: A New Era in Cancer Management (Sponsored by MSD)
Chairperson: Thomas YAU (Hong Kong)

Advancement in Immunotherapy for Head & Neck Cancer
Lillian SIU (Canada)

Immune Checkpoint Inhibitors: New Treatment in Bladder Cancer
Ravindran KANESVARAN (Singapore)

Breakthrough Therapy in MSI-H Colorectal and Other Cancers
Dung Thi LE (USA)
Salon 5-6
13:30 – 14:40 Concurrent Session 7: GI Oncology
Chairpersons: Ka-on LAM (Hong Kong), Yim-kwan LAM (Hong Kong)

Does Harnessing the Immune System Against Colorectal Cancer Work
Han-chong TOH (Singapore)

Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer
Victor LEE (Hong Kong)

What Have We Learned from Recent Major Clinical Trials for the Management of GEP-NET?
(Sponsored by Ipsen)
Salon 5-6
Concurrent Session 8: Gynae Oncology
Chairpersons: Karen CHAN (Hong Kong), Bradley J. MONK (USA)

Targeted Therapy in Cervical Cancer
Bradley J. MONK (USA)

Primary Debulking Surgery (PDS) vs Interval Debulking Surgery (IDS): This is the Question for More Than 20 Years in the Surgical Management of Advanced Ovarian Cancer
Sang-Yoon PARK (South Korea)

Molecular Profiling of Ovarian Cancers to Optimize Therapy
David TAN (Singapore)
Salon 1-4
14:40 – 15:00 Coffee Tea Break & Exhibition  (Sponsored by Eli Lilly)
15:00 – 17:00 Plenary Lecture 4: Advances in Global Oncology Practice
Chairpersons: Joanne CHIU (Hong Kong), Gilberto de Lima LOPES, Jr (USA)

What is Global Oncology?
Gilberto de Lima LOPES, Jr (USA)

Essential Pillars to Advance Oncology Practice
Brian O’SULLIVAN (Canada)

Renal Cell Cancer: Present and Future
Bernard ESCUDIER (France)

The Development of CDK 4/6 Inhibitors: From Bench to Clinic
Richard FINN (USA)
Salon 5-6
17:00 Closing Ceremony
Salon 5-6

The programme is subject to change without prior notice.